Culturally Sensitive Video Targeting Black Men May Help Increase Awareness About Prostate Cancer
SAN DIEGO – A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants...
Search/Filter
Loading...
Proteogenomic Signatures May Help Identify Risk of Prostate Cancer Progression in Patients with African and European Ancestries
SAN DIEGO – Certain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated...
AZD1390 With Radiotherapy Shows Manageable Safety Profile and Preliminary Efficacy for Patients with Glioblastoma in Phase I Trial
SAN DIEGO – AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recurrent...
Artificial Intelligence Analysis of DNA Fragmentomes and Protein Biomarkers Noninvasively Detects Ovarian Cancer
SAN DIEGO – A blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the...
Investigational Personalized Vaccine Provides Clinical Benefit for Some Patients with Resected Head and Neck Cancers
SAN DIEGO – TG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease...
American Association for Cancer Research Inaugurates New Leadership During AACR Annual Meeting 2024
Patricia M. LoRusso, DO, PhD (hc), FAACR, begins term as AACR President SAN DIEGO – The members of the...
An Exosome-based Liquid Biopsy Shows Promise for Early Detection of Pancreatic Cancer
SAN DIEGO – An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with...
Next-generation PARP Inhibitor Demonstrates Clinical Benefit in Patients with Homologous Recombination Repair-deficient Breast Cancer
Drug has higher selectivity for PARP1, improving safety and tolerability SAN DIEGO – Saruparib, a selective inhibitor of poly-ADP...
Adagrasib Plus Cetuximab May Provide Clinical Benefit in Patients With KRASG12C-mutated Colorectal Cancer
SAN DIEGO – A combination of the KRASG12C inhibitor adagrasib (Krazati) and the anti-epidermal growth factor receptor (EGFR) antibody...
A Biologic Drug-Device Combination Immunotherapy Shows Promise for Patients with Metastatic Prostate Cancer
The investigational therapy uses a cold-temperature probe to kill a portion of prostate cancer cells and release tumor-specific neoantigens...